As such, payers should consider: Starting members on tailored weight loss solutions before authorizing GLP-1 treatment coverage Covering holistic programs inclusive of GLP-1 therapies Including conditional terms that provide short-term coverage for GLP-1 patients and Transition patients on to longer-term sustainable programs, such as: Newtopias GLP-1 Sustain is a habit-changing platform that ensures short-term GLP-1 benefits last through long-term change, supporting an eventual positive ROI
This FDA approval is based on results from the FLOW phase IIIb kidney outcomes trial investigating the effects of once-weekly Ozempic injection on major kidney and cardiovascular outcomes in adults with type 2 diabetes and CKD
Foreign substances enter a space the immune system monitors closely
More specifically, it causes the active forms to convert to cyanocobalamin, causing a functional deficiency
Piperine can raise curcumin absorption, but it may also affect how other substances are handled in the body
I find the remarkable growth of the GLP-1 receptor agonist market to be significant not only for diabetes and obesity care, but also for the future of brain health